Statistics

Total Visits

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program40

Select a period of time:

Number of views in the range

Views
Bosutinib apears to be safe, with low cross intolerance, in patients treated in 4th line. Results of the Spanish compassionate use program28

Views

Views
February 20253
March 202511
April 20251
May 20252
June 20250
July 202511
August 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
Brazil6
Hong Kong2
Argentina1
Colombia1
Spain1
United Kingdom1
Italy1
United States1
 

Top cities views

Views
Hong Kong2
Barranquilla1
Campinas1
Campo Grande1
Cornélio Procópio1
Duns1
Goiânia1
Lanús1
Marano di Napoli1
New York1